Tech Company Financing Transactions
Intensity Therapeutics Funding Round
On 6/29/2016, Intensity Therapeutics raised $10 million in Series A financing from Batterson Venture Capital and private investors.
Transaction Overview
Company Name
Announced On
6/29/2016
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will be used to fund operations, manufacture the clinical supplies, permit the needed regulatory filings and conduct a series of clinical trial cohorts in cancer patients with various tumor types.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
61 Wilton Rd. 3rd Floor
Westport, CT 06880
USA
Westport, CT 06880
USA
Phone
Email Address
Overview
Intensity Therapeutics is a biotechnology company whose mission is to greatly extend the lives of cancer patients. Late stage solid cancer consists of well-defined visible tumors and unseen micro-metastases either in the blood or body tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lewis Bender
Chief Medical Officer
Ian Walters
Controller
John Wesolowski
Browse more venture capital transactions:
Prev: 6/29/2016: Compass venture capital transaction
Next: 6/29/2016: Caretaker venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs